07:37 AM EST, 12/02/2024 (MT Newswires) -- Purple Biotech ( PPBT ) shares were up 61% pre-bell Monday after the company said that final data from a phase 2 trial of its oncology drug candidate, CM24, demonstrated "clear and consistent improvement across all efficacy endpoints."

Eshallgo ( EHGO ) stock was 35% higher, reversing Friday's losses.

Cabaletta Bio ( CABA ) shares were up 23%, extending Friday's gains.